Davion Healthcare Plc(DAVI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 7:59 PM ET (Korea 10/24 08:59)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 46.08% | Shs Outstand | 25.0M | Perf Week | - |
| Market Cap | 0.15B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 13.5M | Perf Month | - |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | - |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | - | Perf YTD | -51.02% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -51.22% ($12.30) | Perf Year | - |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | -36.99% ($9.52) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 4.38 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | - | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -32.01% ($8.82) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -32.01% ($8.82) | Rel Volume | 0.86 | Prev Close | $11.65 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -32.01% ($8.82) | Avg Volume(3M) | 0.56M | Price | $6 |
| IPO | - | Option/Short | No/No | Trades | 3961 | Volume | 479,540 | Change | -48.5% |
Davion Healthcare PlcDAVI | NASD | Medical Devices 🧪 아일랜드에 본사를 둔 디지털 헬스케어 기업으로, 비침습 가정용 건강 모니터링 기술을 개발하고 상업화합니다. 대표 제품은 체온 변화를 활용한 가정용 유방 건강 스크리닝 기기이며, 족부 순환·피부·상처·혈압 관련 제품군으로 영역을 넓히고 있습니다. 자체 기술 라이선스와 인수 기반 유통망 구축을 함께 추진하며 나스닥에 상장했습니다.
Over the past 1 year, on the lower side
51% below its 1-year high.
Traded about as much as usual. That is 86% of its average volume.
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Shareholder Composition Guide
Tap to view numbers
It ranks #81 of 143 in the industry
Based on market cap of $150M.
CATX#79 Perspective Therapeutics Inc $184M PER - 
STIM#80 Neuronetics Inc $161M PER - DAVI#81 Davion Healthcare Plc $150M PER - 
MXCT#82 MaxCyte Inc $144M PER - 
QTRX#83 Quanterix Corp $135M PER - 
FAQ
What kind of company is DAVI?
DAVI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of DAVI?
The market cap of DAVI is approximately $150M, ranking 4,215 within its sector.
What is the 52-week high and low for DAVI?
DAVI has recorded a 52-week high of $12.30 and a low of $9.52.
